Have you ever wondered why we care about most parts of the body, but not on their feet? Although it is pain, swelling and heaviness in the legs protects us from a full life and deprive the usual pleasures. How to protect feet from chronic venous insufficiency, tell our article.
Chronic venous insufficiency (CVI) is observed in more than 50% of adults, mostly brand viagra online aged 30-50 years. More than 65% of them - were women. Negative impact of chronic venous insufficiency on quality of life depends on the extent and severity of the pathological process. Patients with lesions of moderate severity did not feel comfortable, rather, an aesthetic nature, while the further development of the disease is accompanied by another, and pain. Women with moderate CVI complain primarily about the inconvenience of cosmetic (2 / 3 of all women), pain in the lower extremities and restrictions associated with CVD, there are equally common in men and women.
Chronic venous insufficiency - a disease of the veins, which is characterized by an increase in luminal diameter, thinning of the venous wall and the formation of "nodes" - anevrizmopodobnyh local extensions. The external signals CVI include "spider veins", "spider" and "mesh", as well as various seals in the legs and protruding veins. According to scientists, the main external factor contributing to varicose veins - bipedalism. As we know, there are no four-footed animals with chronic venous insufficiency, and the person the opportunity to walk on two legs to earn the risk pays chronic varicose veins. This risk increases significantly in people who have a lot to stand during the day, such as the sellers and hairdressers. But remember that sedentary work is not an escape from chronic venous insufficiency, in this case, circulation suffers in the same way as in the standing work. They do not like the veins and long walks - any dangerous monotony, and only the alternation of different types of loads may prevent the development of CVI. Significant role played by heredity - at CVI in one of the parents the child inherits it from the probability to 47%, while the disease in both parents - up to 89%.
In the development of the disease are three stages: compensation, and decompensation subcompensation. In the first stage of the disease are visible extended venous sites, there are complaints of fatigue and a feeling of heaviness in the legs, sometimes there is a local temperature rise in the region in knots. During stage subcompensation pain exacerbated the feeling of fullness in the affected limbs begin to disturb the swelling, which disappear after a long stay lying down with legs elevated. In decompensated swelling already observed continuously and virtually disappear, becoming visibly marked increase in venous sites, as well as diagnosed by enzymatic, metabolic and trophic disorders in the tissues.
Obviously, the expected beginning of the third stage of the disease is not necessary, it can be life threatening. The disease should be treated when the first complaints, and better yet - to prevent their occurrence and prevent the development of CVI. With the accumulation of clinical experience in the light of the pathogenesis of chronic venous insufficiency of the lower extremities (HVNNK) it became clear that so popular earlier surgical intervention is not always able to solve the problem and should pay attention to conservative therapy. Pharmacotherapy can arrest the clinical manifestations and to prevent complications, improve the tone of the venous wall, adjust hemorheological disorders and significantly improve the processes of microcirculation.
In the development of chronic venous insufficiency are three stages:
• compensation - has been an increase venous sites, there are complaints of fatigue and a feeling of heaviness in the legs, sometimes there is a local temperature rise in knots;
• subindemnification - pain exacerbated the feeling of fullness in the affected limbs begin to disturb the swelling, which disappear after a long stay lying down with legs elevated;
• decompensation - edema observed continuously and virtually disappear, becoming visibly marked increase in venous sites, as well as diagnosed by enzymatic, metabolic and trophic disorders in the tissues.
Because drug treatment of CVI is carried out in a long time, the drugs used should have a minimum of undesirable effects, good tolerability and be comfortable to use. Most commercially available phytotherapeutic drugs for the treatment of CVI have similar properties, but only for a few of them have efficacy has been proven in clinical trials.
During the experiments, it was confirmed that the leaf extract of red grapes contains pharmacologically active flavonoids, the main ones are quercetin-glucuronide and izokvertsetin. During the oxidation of flavonoids formation of free radicals, which may affect enzymatic processes. Preparations containing leaf extract of red grapes, have a protective effect on the epithelium of blood vessels and increase the elasticity of blood vessels, thus normalizing vascular permeability, and affecting the system of "hyaluronic acid - hyaluronidase. It was found that decreasing the permeability of the vascular wall to plasma proteins from blood vessels into surrounding tissue slows the formation of edema and can reduce existing edema.
Leaf extract of red grapes is created on the basis of modern technologies with the use of natural extractive substances. It is worth emphasizing that the safety of this medicinal plant is especially important for patients with chronic diseases who were forced to receive treatment for a long time.
Currently, modern flebotropnye drugs through multivalent mechanism of action and minimal side effects are widely used for pharmacological correction of CVI. They can be used as monotherapy, in combination with surgery, elastic compression, physiotherapy procedures and remedial actions.
Reception preparations containing flavonoids, can cut or significantly reduce the symptoms of disease.
Expert opinion
Rostislav SINITSYN, doctor of the highest category of the Department of Surgery NMHTS them. NI Pirogov
As is known, the veins of the lower limbs represent a tree, consisting of large, medium and small branches, between which there are connections. Clearance of lower limb veins is almost 10 times greater than the lumen of the arteries. The wall of the vein, in contrast to the arterial wall, it does not express the muscle layer, resulting in blood in the veins rises under the influence of blood pressure. The rate of blood flow through the veins have a big effect to reduce the leg muscles - the muscle tone. Contracting, the muscles cause blood to climb up and even complete rest the muscles are in a constant tone, which promotes blood flow. When a person is in an upright position, the hydrostatic pressure acts in a direction opposite to the current venous blood, and creates in the veins of the lower limbs high blood pressure. Backflow of blood in a standing position and during exercise oppose venous valves. With congenital or acquired weakness of the connective tissue of muscles and vein walls precisely organized circulatory system begins to falter. The main risk factors that vitiate or contribute to the development of the disease are age, heredity, gender, multiple pregnancy, obesity, type of work, sedentary lifestyle, prolonged static loads and high growth.
It must be noted that the population of civilized countries are increasingly sedentary both at work and at home, sitting in front of the TV, and an increase in the amount of free time, only a few people associated with sports. Professions associated with the position of standing or sitting motionless, as characterized by an increased brand name levitra risk of developing varicose veins. This risk increases depending on the length of the profession. Smoking is known to cause various forms of arteriopathy. Statistics show that smokers are more likely to suffer from CVD than non-smokers. Other risk factors include poor nutrition, constipation, insufficient fiber intake, inguinal hernia and elevated blood pressure. In Western Europe, the cost of treatment of diseases of veins are about 2%. Faster and more often they lead to disability - access to the disability of the complications of venous disease are among the highest. However, most relevant for each patient with CVI - a substantial decline in the quality of life. To prevent venous disorders should try to lose weight, improve blood circulation of regular physical exercise as a long-haul flights on the plane every hour or two to walk ten minutes through the cabin, do not wear tight tights and socks, and with the least complaints of pain in my legs to see a doctor.
Today phlebologist arsenal of treatment options is very wide. Basis of the modern treatment of chronic venous disease are minimally invasive technology using endoscopic techniques, medical lasers, radio waves, and cryosurgery. Means of ultrasonic imaging provide accurate surgery, providing intra-and postoperative control. But, as it had not improved today, various surgical methods, a problem which is called "chronic venous disease, is multifaceted and requires an integrated approach. Indispensable for the treatment of CVI venoaktivnye drugs. Venoaktivnye products (VAP) - a term that was adopted by the international phlebological recommendations. Flebotropnye drugs are the basis for medical treatment, because they increase the outflow of the lower extremities. This is achieved by summing up the impacts on various parts of microvasculature. The main products is a fleboprotektivnyh flebotonicheskoe action, many of them directly affect the contractility of the venous wall, as well as stimulate lymph flow and possess anti-inflammatory activity. It is this feature that allows to work on the basic pathogenesis HVNNK brought together a number of drugs in the group fleboprotektorov and made their base in the conservative treatment. Many drugs are related to the number of VAP are of vegetable origin and presented as fitolekarstva. They are administered orally, tolerance to these drugs is good, side effects are rare. Important - they show a clear anti-edema effect, and also contribute to the disappearance or reduction of symptoms.
sulfonylureas
clinical research
during meals
traditional medicine
No hay comentarios:
Publicar un comentario